2014 has been a great year for investors in insurance companies. Indeed, the share price returns of the likes of Direct Line (LSE: DLG), Aviva (LSE: AV) (NYSE: AV.US), Old Mutual (LSE: OML) and Standard Life (LSE: SL) have all beaten the return on the FTSE 100 year-to-date.
Looking ahead, though, which of the four stocks is the best buy?
Should you invest £1,000 in Abrdn right now?
When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Abrdn made the list?
Direct Line
Even though results released this week by Direct Line showed that the company is on-track to meet its full-year guidance, shares in the company fell post-release. A possible reason for this could be profit taking, with Direct Line’s share price having risen by an impressive 11% since the turn of the year.
Looking ahead, though, there could be more share price gains to come from Direct Line. That’s because it currently yields a whopping 7.9%, with dividends due to be covered 1.2 times by profit next year. This is a hugely appealing yield and, with interest rates set to remain low over the medium term, increased investor hunger for dividends could send demand (and Direct Line’s share price) much higher.
Aviva
Also performing well in 2014 is Aviva, with its share price recording gains of 16% since the turn of the year. A key reason for this has been a sound turnaround strategy that is causing investor sentiment to improve significantly.
Although dividends are unlikely to return to their 2011 highs in the near-term, Aviva’s income prospects are considerable. Shares in the company currently yield 3.2% but, with dividends set to increase at a brisk pace next year, Aviva could be yielding as much as 3.7% in 2015. This impressive income potential, when combined with a price to earnings (P/E) ratio of just 11, means that Aviva could be a great buy right now.
Old Mutual
Although its share price has risen by just 2.5% in 2014, Old Mutual has huge potential. For starters, it offers a top notch yield of 4.5% and, with dividends per share set to grow by 12% next year, this could be as much as 5.1% next year.
However, it’s with regard to Old Mutual’s growth prospects where its real potential lies. Indeed, it is forecast to increase earnings by a hugely impressive 15% next year and, despite this, trade on a P/E ratio of just 11.6. This means that its price to earnings growth (PEG) ratio of 0.8 indicates growth at a very reasonable price, meaning Old Mutual could be a star performer over the medium term.
Standard Life
With share price gains of 9% in 2014, Standard Life has easily outperformed the FTSE 100. However there could be much more to come, since it is forecast to increase the bottom line by a hugely impressive 10% in the current year, and by a further 21% next year.
Although shares in Standard Life trade on a P/E ratio of 18.1, such strong earnings growth prospects mean that it has a PEG ratio of just 0.8. And, when a yield of 4.3% is added to the mix, it means that Standard Life has huge appeal to both growth and income investors and, as a result, could see its share price move upwards over the medium term.
Looking Ahead
While all four stocks have huge potential and could be worth buying right now, the income prospects, growth potential and super-low valuation of Old Mutual combine to make it my top pick of the four insurers.
